Startups
SiteSeal® and SiteSeal® SV® are next generation vascular closure devices that simulate manual comprehension while removing associated variability.
Overview
Location
United States, Kansas, Olathe
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 13, 2021 | Andrea Natale, M.D. Joins Ensite Vascular’s Medical Advisory Board | OLATHE, Kan. (PRWEB) May 13, 2021 Ensite Vascular announces that Andrea Natale, M.D., F.A.C.C, F.H.R.S., F.E.S.C., Executive Medical Director of Texas Cardiac Arrhythmia Institute at St. David’s Medical Center in Austin, Texas, has accepted... |
| Apr 20, 2021 | EnsiteVascular receives FDA market clearance for SiteSeal™ SV vascular closing device’s second indication | “Currently, there is no other device with FDA market clearance for closure of brachial artery access sites. With FDA’s clearance for SiteSeal SV... we are making progress toward a new and better standard of care for these endovascular proce... |
| Feb 10, 2021 | EnsiteVascular Announces Formation of Medical Advisory Board | “Creating our Medical Advisory Board is an important milestone for EnsiteVascular. It’s a privilege to have the caliber of cardiologists we have as initial MAB members,” - Tom Reidy, EnsiteVascular’s president and CEO. OLATHE, Kan. (PRWEB) ... |
Reviews 0
FAQ about EnsiteVascular
What has the press written about EnsiteVascular?
Parsers VC has collected 4 articles mentioning EnsiteVascular, among them “Andrea Natale, M.D. Joins Ensite Vascular’s Medical Advisory Board” (May 13, 2021) and “EnsiteVascular receives FDA market clearance for SiteSeal™ SV vascular closing device’s second indication” (Apr 20, 2021).
Is EnsiteVascular still active?
Yes, EnsiteVascular is active; its latest activity on Parsers VC dates from Jun 7, 2022.